MAPT and Cognitive impairment: Nevertheless, in spite of the failure in improving cognitive defects, MB treatment was still able to reduce sarcosyl-insoluble Tau, although to a minor extent in case of TauΔK compared to preventive MB treatment paradigms (Figure 4).